daunorubicin has been researched along with Lymphoma, Mantle-Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avigdor, A; Avivi, I; Benyamini, N; Davidson, T; Goshen, E; Kedmi, M; Nagler, A; Ribakovsky, E; Tadmor, T | 1 |
Bhagat, G; Dybkaer, K; Farnen, JP; Han van Krieken, J; Hsi, ED; Medeiros, LJ; Montes-Moreno, S; Møller, MB; O'Malley, DP; Ok, CY; Orazi, A; Piris, MA; Ponzoni, M; Richards, KL; Tzankov, A; Visco, C; Winter, JN; Xu-Monette, ZY; Young, KH; Zu, Y | 1 |
Gong, Y; Naren, D; Shi, F; Shi, R; Wu, J; Yang, X | 1 |
3 other study(ies) available for daunorubicin and Lymphoma, Mantle-Cell
Article | Year |
---|---|
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Proportional Hazards Models; Retrospective Studies; Rituximab; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous; Vincristine | 2014 |
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Murine-Derived; Cyclin D1; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Mice; Middle Aged; Prednisone; Prevalence; Prognosis; Rituximab; Vincristine; Young Adult | 2014 |
The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Indoles; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |